This is the first nationwide study aimed to evaluate in-hospital mortality and comorbidities of extremely low birth weight (ELBW) infants in Thailand between 2015-2020. Data of ELBW infants were collected from the National Health Coverage Scheme. The incidence of ELBW Thai infants was 1.75 per 1000 live births. Sixty-five percent of ELBW infants were delivered in tertiary-care facilities, with 63% surviving until discharge. In-hospital mortality was 36.9%. Non-invasive respiratory supports were documented in just 17.6% of the study population, whereas total parenteral nutrition was used in 52.3% of neonates. There were several comorbidities, with the three most frequent including respiratory distress syndrome (70.7%), neonatal jaundice (66.7%), and sepsis (60.4%). The median hospitalization cost for one ELBW infant who survived was 296,438.40 baht ($8719). Conclusion: Thailand had an acceptable ELBW infant survival rate (63%), but comorbidities remained particularly severe and cost one hundred times the median hospital cost for one ELBW infant that survived in comparison to a normal newborn infant. Better health outcomes require strategies to raise awareness of the issues and the appropriate implementation of evidence-based solutions, particularly improving neonatal care facilities, as well as early referral of high-risk pregnant women and neonates, which will aid in the future reduction of neonatal morbidities and mortalities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776691PMC
http://dx.doi.org/10.3390/children9121825DOI Listing

Publication Analysis

Top Keywords

elbw infants
12
elbw infant
12
mortality comorbidities
8
comorbidities extremely
8
extremely low
8
low birth
8
birth weight
8
thai infants
8
in-hospital mortality
8
cost elbw
8

Similar Publications

Background: Unbound bilirubin (UB) was measured on day 5 ± 1 in 1101 ELBW newborns in the Aggressive vs Conservative Phototherapy randomized controlled trial. We accessed this dataset to quantify the UB-mediated risk of severe neurodevelopmental impairment (sNDI) in extremely low birthweight (ELBW) newborns.

Methods: UB levels were standardized within laboratories as z-score percentiles.

View Article and Find Full Text PDF

Background: Studies on how birth body mass index (BMI) affects health outcomes in preterm infants are relatively limited.

Aim: To analyze the association between BMI at birth and neonatal health outcomes in extremely low and very low birth weight preterm infants in China.

Methods: Used data from the Chinese Premature Infant Informatization Platform (2022-2023).

View Article and Find Full Text PDF

: To obtain bioelectrical data to assess nutritional status for extremely low-birth-weight (ELBW) infants upon reaching term-corrected age. : A descriptive, observational, prospective, and single-center study, which included ELBW preterm infants was performed. The study variables collected were gestational age, sex, and anthropometry at birth and at term-corrected age.

View Article and Find Full Text PDF
Article Synopsis
  • Very low birth weight (VLBW) infants create significant caregiving challenges for families, making family resilience essential for managing stress and adapting after discharge.
  • The study aimed to assess how family resilience affects mothers of VLBW and extremely low birth weight (ELBW) infants, focusing on aspects like social support, family functioning, and parenting stress over 3 and 6 months.
  • Results showed that mothers reported moderate-to-high family resilience levels, with social support and parenting stress being strong indicators of resilience, highlighting the importance of support systems in navigating the challenges of caring for premature infants.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored the role of intratracheal budesonide combined with surfactant in reducing death or bronchopulmonary dysplasia (BPD) in extremely low birth weight (ELBW) infants with respiratory distress syndrome (RDS).
  • The results showed no significant difference in the rates of death or BPD between the group that received the combination treatment and the historical group that received surfactant alone.
  • Although the combination treatment was found to be safe and feasible, further larger studies are needed to confirm any potential benefits.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!